Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Diabetes 57:1788-1789, 2008
DOI: 10.2337/db08-0530
© 2008 by the American Diabetes Association
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by James, E. A.
Right arrow Articles by Kwok, W. W.
PubMed
Right arrow PubMed Citation
Right arrow Articles by James, E. A.
Right arrow Articles by Kwok, W. W.
Related Collections
Right arrowRelated Article
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Commentary

Low-Affinity Major Histocompatibility Complex–Binding Peptides in Type 1 Diabetes

Eddie A. James1, and William W. Kwok1,2

1 Benaroya Research Institute, Virginia Mason Medical Center, Seattle, Washington
2 Department of Immunology, University of Washington, Seattle, Washington

Corresponding author: William W. Kwok, bkwok@benaroyaresearch.org

The first 20% of the full text of this article appears below.

Type 1 diabetes is characterized by T-cell–mediated destruction of insulin-producing β-cells. The strong association between autoimmune diabetes and certain susceptible major histocompatibility complex (MHC) class II alleles suggests that T-cell activation by self-peptides presented via these MHC class II alleles plays a critical role in the disorder's pathogenesis. A diverse repertoire of T-cells is generated in the thymus, first through positive selection on MHC and self-peptide within the thymic cortex. This process requires adequate peptide presentation through interactions with MHC and sufficient T-cell receptor (TCR) signaling through the TCR/MHC/self-peptide complex (Fig. 1). As such, all T-cells in normal physiology are intrinsically self-reactive. However, subsequent negative selection of self-reactive T-cells in the thymic medulla should lead to clonal deletion for TCRs that recognize self-peptide/MHC with high affinity. Although some self-reactive, high-avidity T-cells do escape into peripheral circulation, suboptimal recognition of MHC/self-peptide by the TCRs may be required for T-cells to escape tolerance mechanisms. This idea is supported by experimental observations that the affinity of TCRs for MHC/self-peptide is generally lower than that for MHC/foreign peptide and that the interactions of autoreactive TCRs to MHC/self-peptide appear to be less extensive than to foreign peptide (1,2). In light of the opposing mechanisms of positive and negative selection, fundamental questions remain regarding the affinity of TCR/MHC/self-peptide interactions that give rise to autoreactive T-cell responses.


Figure Removed (Available Only in the Full Text)
View larger version (14K):



 
FIG. 1. The T-cell repertoire is determined by positive and negative selection. T-cells with . . . [Full Text of this Article]

 

Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Related Article:

Weak Proinsulin Peptide–Major Histocompatibility Complexes Are Targeted in Autoimmune Diabetes in Mice
Matteo G. Levisetti, Danna M. Lewis, Anish Suri, and Emil R. Unanue
Diabetes 2008 57: 1852-1860. [Abstract] [Full Text] [PDF]






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2008 by the American Diabetes Association.